159 related articles for article (PubMed ID: 11922536)
1. Use of a peripheral dexa measurement for osteoporosis screening.
Kirk JK; Nichols M; Spangler JG
Fam Med; 2002 Mar; 34(3):201-5. PubMed ID: 11922536
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis: what are the implications of DEXA scanning 'high risk' women in primary care?
Thomas E; Richardson JC; Irvine A; Hassell AB; Hay EM
Fam Pract; 2003 Jun; 20(3):289-93. PubMed ID: 12738698
[TBL] [Abstract][Full Text] [Related]
3. Practice variation in the diagnosis and treatment of osteoporosis: a case for more effective physician education in primary care.
Saadi H; Litaker D; Mills W; Kippes C; Richmond B; Licata A
J Womens Health Gend Based Med; 1999; 8(6):767-71. PubMed ID: 10495258
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis screening and education in community pharmacies using a team approach.
MacLaughlin EJ; MacLaughlin AA; Snella KA; Winston TS; Fike DS; Raehl CR
Pharmacotherapy; 2005 Mar; 25(3):379-86. PubMed ID: 15843285
[TBL] [Abstract][Full Text] [Related]
5. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
[TBL] [Abstract][Full Text] [Related]
6. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
Gupta G; Aronow WS
J Am Med Dir Assoc; 2003; 4(4):200-2. PubMed ID: 12837141
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis.
Naunton M; Peterson GM; Jones G
Ann Pharmacother; 2006 Jan; 40(1):38-44. PubMed ID: 16303984
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density among postmenopausal Saudi women.
Sadat-Ali M; Al-Habdan IM; Al-Mulhim FA; El-Hassan AY
Saudi Med J; 2004 Nov; 25(11):1623-5. PubMed ID: 15573189
[TBL] [Abstract][Full Text] [Related]
9. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women.
Sadat-Ali M; Al-Habdan I; Al-Mulhim AA; El-Hassan AY
Saudi Med J; 2005 Oct; 26(10):1588-90. PubMed ID: 16228061
[TBL] [Abstract][Full Text] [Related]
10. Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis.
Law AV; Shapiro K
J Eval Clin Pract; 2005 Jun; 11(3):247-55. PubMed ID: 15869555
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry.
El-Desouki MI; Sherafzal MS; Othman SA
Saudi Med J; 2005 Sep; 26(9):1346-50. PubMed ID: 16155646
[TBL] [Abstract][Full Text] [Related]
12. PIXI bone density screening for osteoporosis in postmenopausal women.
Lawrenson R; Nicholls P; Rivers-Latham R; Brown T; Barnardo J; Gray R
Maturitas; 2006 Feb; 53(3):245-51. PubMed ID: 15985347
[TBL] [Abstract][Full Text] [Related]
13. Initiation of osteoporosis treatment after bone mineral density testing.
Pressman A; Forsyth B; Ettinger B; Tosteson AN
Osteoporos Int; 2001; 12(5):337-42. PubMed ID: 11444079
[TBL] [Abstract][Full Text] [Related]
14. Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria.
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 1999; 10(6):441-9. PubMed ID: 10663343
[TBL] [Abstract][Full Text] [Related]
15. The role of serial bone mineral density testing for osteoporosis.
Crandall C
J Womens Health Gend Based Med; 2001 Nov; 10(9):887-95. PubMed ID: 11747684
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
Hough S
S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
[TBL] [Abstract][Full Text] [Related]
17. Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention.
McConaha JL; Berdine HJ; Skomo ML; Laux RV; Higginbotham SK; O'Neil CK
J Pharm Pract; 2014 Feb; 27(1):25-30. PubMed ID: 24108433
[TBL] [Abstract][Full Text] [Related]
18. An ongoing six-year innovative osteoporosis disease management program: challenges and success in an IPA physician group environment.
Woo A; Hittell J; Beardsley C; Noh C; Stoukides CA; Kaul AF
Dis Manag; 2004; 7(3):216-25. PubMed ID: 15669581
[TBL] [Abstract][Full Text] [Related]
19. Impact and feasibility of a community pharmacy bone mineral density screening and education program.
Cerulli J; Zeolla MM
J Am Pharm Assoc (2003); 2004; 44(2):161-7. PubMed ID: 15098850
[TBL] [Abstract][Full Text] [Related]
20. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
Frost ML; Blake GM; Fogelman I
J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
